MedTrace Logo

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

NCT06078605 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-10-12

No results posted yet for this study

Summary

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients : Clinical Trial, Cross-over Design, Double-blind, Placebo-control, Randomized, Single-center Study

Conditions

Interventions

OTHER

Nicotinamide(Mitovita)

Nicotinamide(VitaminB3)

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Hanlim Pharm. Co., Ltd.

    collaborator INDUSTRY

  • CHA University

    lead OTHER

Principal Investigators

  • Seungsoo Rho, MD, PhD · CHA Bundang Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-16
Primary Completion
2024-03-31
Completion
2024-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06078605 on ClinicalTrials.gov